RZLT | RezoluteNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$4.01
+$0.13 (+3.35%)

Rezolute (RZLT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $4.01 vs 50 $4.21 / 200 $3.90
Projection
No cross projected
Test
No active test
Last cross
Golden cross 7 Aug 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $3.95 vs 50 $4.06 / 200 $3.69
Projection
Death cross projected in 9 bars
Test
No active test
Last cross
Golden cross week of 13 Jan 2025 ยท projected 14 bars out ยท tested 2 bars

4-hour as of 3 Nov 13:30 ET

Price
below both $4.02 vs 50 $4.11 / 200 $4.51
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Sep 2026 bar 1 ยท projected 27 bars out ยท tested 1 bar

Cross history

15
crosses on record since 2023
8 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Sep 2026Death4-hour27 bars out1 bar cross test
7 Aug 2026Golden moderatedaily30 bars outโ€”
30 Apr 2026Golden4-hour29 bars outโ€”
21 Jan 2026Death steepdaily24 bars outโ€”
18 Dec 2025Death4-hour11 bars outโ€”

About RZLT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.